Corcept Therapeutics
CORT
CORT
80 hedge funds and large institutions have $244M invested in Corcept Therapeutics in 2015 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
14% more capital invested
Capital invested by funds: $214M → $244M (+$29.8M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
80
Holding in Top 10
2
Calls
$2.48M
Puts
$9K
Top Buyers
| 1 | +$2.68M | |
| 2 | +$2.27M | |
| 3 | +$1.81M | |
| 4 |
ISL
Ingalls & Snyder LLC
New York
|
+$1.65M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$1.46M |
Top Sellers
| 1 | -$8.07M | |
| 2 | -$902K | |
| 3 | -$240K | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$237K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$233K |